Clinical Trial Update: Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate [Phase 1, Phase 2]

View source ↗

Summary

Clinical trials for WRSS1, a Shigella sonnei vaccine candidate, completed Phase 1/2 to assess safety and efficacy for dysentery caused by Shigella and related d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea
• Dysentery
• Shigellosis

Drugs mentioned

• WRSS1

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Dysentery, Shigella | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-11-13